Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)

SHA:688580 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	429.11	395.34	455.44	319.67	428.73	376.63
Other Revenue	4.72	4.72	6.78	1.95	1.31	1.74
Revenue	433.83	400.06	462.22	321.62	430.04	378.37
Revenue Growth (YoY)	2.75%	-13.45%	43.72%	-25.21%	13.66%	18.66%
Cost of Revenue	147.66	138.26	149.16	88.52	108.45	99.76
Gross Profit	286.17	261.8	313.06	233.1	321.59	278.6
Selling, General & Admin	135.06	138.92	152.48	129.71	116.08	105.82
Research & Development	42.4	50.61	57.65	43.73	63.52	34.29
Other Operating Expenses	-7.88	-11.64	-14.08	-7.67	-6.97	-4.12
Operating Expenses	171.03	179.33	198.31	166.29	173.52	136.76
Operating Income	115.14	82.48	114.75	66.82	148.07	141.84
Interest Expense	-1.39	-1.31	-1.32	-0.33	-0.18	-0.41
Interest & Investment Income	16.91	21.11	29.9	35.29	37.35	19.85
Other Non Operating Income (Expenses)	0.02	0.14	0.06	-0.2	-0.04	-0.05
EBT Excluding Unusual Items	130.68	102.42	143.39	101.57	185.2	161.23
Gain (Loss) on Sale of Investments	2.42	2.42	-0.96	-	-	-
Gain (Loss) on Sale of Assets	-0.01	-0.01	-0.01	-0.01	-0.01	0.04
Asset Writedown	-0.12	-	-	-	-	-
Other Unusual Items	8.71	8.45	7.6	4.29	12.19	4.81
Pretax Income	141.68	113.28	150.01	105.84	197.38	166.08
Income Tax Expense	15.73	11.31	13.75	12.01	19.84	22.95
Earnings From Continuing Operations	125.95	101.97	136.26	93.83	177.54	143.13
Minority Interest in Earnings	-	-	-	-	0.28	0.52
Net Income	125.95	101.97	136.26	93.83	177.81	143.66
Net Income to Common	125.95	101.97	136.26	93.83	177.81	143.66
Net Income Growth	11.71%	-25.16%	45.23%	-47.23%	23.77%	44.06%
Shares Outstanding (Basic)	96	95	96	96	96	82
Shares Outstanding (Diluted)	96	95	96	96	96	82
Shares Change (YoY)	-0.07%	-0.29%	0.05%	-0.31%	17.41%	13.89%
EPS (Basic)	1.32	1.07	1.43	0.98	1.86	1.76
EPS (Diluted)	1.32	1.07	1.42	0.98	1.85	1.76
EPS Growth	11.80%	-24.95%	45.16%	-47.07%	5.42%	26.50%
Free Cash Flow	57.44	5.21	0.72	-9.45	70.02	109.11
Free Cash Flow Per Share	0.60	0.06	0.01	-0.10	0.73	1.33
Dividend Per Share	0.800	0.800	1.076	0.491	0.930	0.751
Dividend Growth	-25.62%	-25.62%	119.02%	-47.19%	23.87%	-
Gross Margin	65.96%	65.44%	67.73%	72.48%	74.78%	73.63%
Operating Margin	26.54%	20.62%	24.82%	20.77%	34.43%	37.49%
Profit Margin	29.03%	25.49%	29.48%	29.17%	41.35%	37.97%
Free Cash Flow Margin	13.24%	1.30%	0.15%	-2.94%	16.28%	28.84%
EBITDA	136.09	102.56	133.69	82.77	157.96	150.63
EBITDA Margin	31.37%	25.64%	28.92%	25.74%	36.73%	39.81%
D&A For EBITDA	20.94	20.09	18.95	15.95	9.89	8.79
EBIT	115.14	82.48	114.75	66.82	148.07	141.84
EBIT Margin	26.54%	20.62%	24.82%	20.77%	34.43%	37.49%
Effective Tax Rate	11.10%	9.98%	9.17%	11.35%	10.05%	13.82%
Revenue as Reported	433.83	400.06	462.22	321.62	430.04	378.37

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.